Overview

Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

Status:
Unknown status

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.

Phase:

Phase 4

Details

Lead Sponsor:

Ophthalmic Consultants of Boston

Collaborator:

Allergan

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Disinfectants
Fluoroquinolones
Gatifloxacin
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ophthalmic Solutions
Pharmaceutical Solutions